Trinity Biotech (TRIB) EPS (Basic) Growth (5y) (2014 - 2024)
Trinity Biotech (TRIB) EPS (Basic) Growth (5y) (2014 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.82 Mn | 1.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,454.33% |
| Sep 30, 2024 | -139.39% |
| Jun 30, 2024 | 51.18% |
| Mar 31, 2024 | -49.26% |
| Dec 31, 2023 | -1,356.13% |
| Sep 30, 2023 | -43.53% |
| Jun 30, 2023 | -17.82% |
| Mar 31, 2023 | -59.80% |
| Dec 31, 2022 | -1,995.48% |
| Sep 30, 2022 | -68.26% |
| Jun 30, 2022 | -31.99% |
| Mar 31, 2022 | -61.14% |
| Dec 31, 2021 | -1,200.65% |
| Sep 30, 2021 | 36.94% |
| Jun 30, 2021 | -16.03% |
| Mar 31, 2021 | 27.16% |
| Dec 31, 2020 | -42.76% |
| Sep 30, 2020 | -7.89% |
| Jun 30, 2020 | -21.10% |
| Mar 31, 2020 | -21.15% |